These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 618428)

  • 21. [HBs antigen: marker of the relation between hepatitis B virus and primary cancer of the liver: the situation in Brazzaville in 1984].
    Gombe CM
    IARC Sci Publ; 1984; (63):221-6. PubMed ID: 6100270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study of the correlation between primary hepatocellular carcinoma and hepatitis B].
    Lu CQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Feb; 9(1):5-7. PubMed ID: 2838172
    [No Abstract]   [Full Text] [Related]  

  • 23. [HBe Ag/anti-HBe system: results of a study of 66 patients having the hepatitis B surface antigen (HBsAG)].
    Lemaire JM; Borgeot C; Mourrut C; Michel H
    Nouv Presse Med; 1978 Sep; 7(32):2878. PubMed ID: 714681
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence of hepatitis B viral markers in hepatitis B endemic areas of China.
    Luo S; Ye FS; Mo ZC; Su YX; He JS; Zhou CQ; Tong MJ; Henderson BE; Yu MC
    Chin Med J (Engl); 1988 Sep; 101(9):654-8. PubMed ID: 2466618
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].
    Volc-Platzer B; Hanak H; Weiss W; Denk H
    Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary liver carcinoma and markers of virus of type B hepatitis (author's transl)].
    Pedreira JD; Vargas V; Vilaseca J; Esteban R; Hernández-Sánchez JM; Guardia J; Bacardi R
    Med Clin (Barc); 1980 Jun; 75(2):58-60. PubMed ID: 6249978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current developments in hepatology].
    Banciu T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(4):289-300. PubMed ID: 2865791
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hepatitis B vaccines. An evaluation of human plasma extracted vaccines].
    Prince AM; Vnek J
    Fortschr Med; 1982 Oct; 100(40):1839-43. PubMed ID: 6293948
    [No Abstract]   [Full Text] [Related]  

  • 29. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
    Coursaget P; Barres JL; Tortey E; Cotty P; Diop T; Yvonnet B; Sow MT; Mboup S; Diop B; Bocande JE
    Cancer Res; 1986 Mar; 46(3):1492-4. PubMed ID: 3943106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatitis B--a viral oncogene?].
    Weis NM; Krogsgaard K
    Ugeskr Laeger; 2002 Dec; 164(50):5940-4. PubMed ID: 12553116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Localization of HBsAg and HBcAg by peroxidase-labeled antibody].
    Hong SF
    Zhonghua Yi Xue Za Zhi; 1985 Jun; 65(6):352-4. PubMed ID: 2994857
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.
    Gasser RW; Judmaier G; Zur Nedden D; Aufschnaiter M; Hofstaedter F
    Am J Gastroenterol; 1983 May; 78(5):305-8. PubMed ID: 6189392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma grading and HBAg distribution.
    Wang WL; Wang BY; Liu WB; Liu YF
    Chin Med J (Engl); 1983 May; 96(5):330-4. PubMed ID: 6311497
    [No Abstract]   [Full Text] [Related]  

  • 35. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
    Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
    J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Appearance of HBsAg in the liver in cases of hepatocellular carcinoma].
    Szczudrawa J; Urban A; Pomorska I
    Patol Pol; 1984; 35(2):179-89. PubMed ID: 6096796
    [No Abstract]   [Full Text] [Related]  

  • 37. A case/control study of hepatitis B virus serologic markers in Senegalese patients suffering from primary hepatocellular carcinoma.
    Coursaget P; Maupas P; Goudeau A; Chiron JP; Raynaud B; Drucker J; Barin F; Denis F; Diop Mar I; Diop B
    Prog Med Virol; 1981; 27():49-59. PubMed ID: 6262871
    [No Abstract]   [Full Text] [Related]  

  • 38. [Relation between the pathologic grading and the distribution of HBAg in hepatocellular carcinoma].
    Wang WL
    Zhonghua Zhong Liu Za Zhi; 1983 Jan; 5(1):31-3. PubMed ID: 6189684
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of a long-term study of HBsAg in the blood in chronic liver disease].
    Stránský J; Helm R; Hrbác I; Sprincl L; Benda R
    Vnitr Lek; 1983 Jul; 29(6):565-70. PubMed ID: 6613024
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia.
    Swenson PD; Escobar MR; Silverman JF
    Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.